Healthcare resource use and costs of multiple sclerosis patients in Germany before and during fampridine treatment

Overview of attention for article published in BMC Neurology, March 2017

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 11 Dimensions

Readers on

mendeley: 39 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 11 publications that cite this research output.

11

The most recent citing publications are shown below. View all 11 publications that cite this research output on Dimensions.

Assessment of motor function in patients with multiple sclerosis treated with Fampridine using motor-evoked potentials

Article in Balneo and PRM Research Journal (December 2023)

The socioeconomic impact of disability progression in multiple sclerosis: A retrospective cohort study of the German NeuroTransData (NTD) registry

Article in Multiple Sclerosis Journal - Experimental Translational and Clinical (July 2023)

Real-world patient characteristics, treatment patterns and costs in relapsing multiple sclerosis patients treated with glatiramer acetate, dimethyl fumarate or teriflunomide in Germany

Article in Neurodegenerative Disease Management (December 2021)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.